Insights

Expanding Market Presence Italfarmaco's active presence across multiple European, Latin American, African, and North American markets, combined with recent partnerships and product launches, presents opportunities to offer specialized pharmaceutical ingredients, manufacturing solutions, and distribution channels tailored to diverse regional needs.

Innovative Oncology Focus With significant research investment and recent approvals for Duchenne muscular dystrophy treatments, the company is positioned to expand its portfolio of advanced therapies, creating demand for high-quality raw materials, formulation services, and innovative drug delivery technologies.

Research and Development Growth Its strong focus on immunology and cardiovascular research, complemented by ongoing clinical development and licensing agreements, indicates a need for specialized research reagents, contract manufacturing, and lab equipment providers to support their R&D pipeline.

Strategic Partnerships Recent collaborations with companies like Nerviano Medical Sciences and Multicarepharma highlight opportunities for joint development, licensing, and contract manufacturing services, especially in peptide-drug conjugates and regional market expansion.

Regulatory and Market Validation The company's EMA validation and recent approval filings for key treatments suggest a growing pipeline of regulated pharmaceutical products, creating opportunities for compliance consulting, manufacturing scale-up, and distribution support to facilitate global market entry.

Similar companies to ITALFARMACO S.P.A.

ITALFARMACO S.P.A. Tech Stack

ITALFARMACO S.P.A. uses 8 technology products and services including oEmbed, Apple iCloud Mail, Font Awesome, and more. Explore ITALFARMACO S.P.A.'s tech stack below.

  • oEmbed
    Dev Tools
  • Apple iCloud Mail
    Email
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • Bootstrap
    UI Frameworks
  • Microsoft IIS
    Web Servers

Media & News

ITALFARMACO S.P.A.'s Email Address Formats

ITALFARMACO S.P.A. uses at least 1 format(s):
ITALFARMACO S.P.A. Email FormatsExamplePercentage
F.Last@italfarmaco.comJ.Doe@italfarmaco.com
86%
FLast@italfarmaco.comJDoe@italfarmaco.com
12%
First.Last@italfarmaco.comJohn.Doe@italfarmaco.com
1%
FMiddleLast@italfarmaco.comJMichaelDoe@italfarmaco.com
1%

Frequently Asked Questions

What is ITALFARMACO S.P.A.'s official website and social media links?

Minus sign iconPlus sign icon
ITALFARMACO S.P.A.'s official website is italfarmaco.com and has social profiles on LinkedIn.

How much revenue does ITALFARMACO S.P.A. generate?

Minus sign iconPlus sign icon
As of December 2025, ITALFARMACO S.P.A.'s annual revenue is estimated to be $868M.

What is ITALFARMACO S.P.A.'s NAICS code?

Minus sign iconPlus sign icon
ITALFARMACO S.P.A.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ITALFARMACO S.P.A. have currently?

Minus sign iconPlus sign icon
As of December 2025, ITALFARMACO S.P.A. has approximately 522 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Chief Financial Officer: M. C.Vice President Corporate Human Resources: R. B.Head Of Market Access & Government Affairs | Rare Disease: V. D.. Explore ITALFARMACO S.P.A.'s employee directory with LeadIQ.

What industry does ITALFARMACO S.P.A. belong to?

Minus sign iconPlus sign icon
ITALFARMACO S.P.A. operates in the Pharmaceutical Manufacturing industry.

What technology does ITALFARMACO S.P.A. use?

Minus sign iconPlus sign icon
ITALFARMACO S.P.A.'s tech stack includes oEmbedApple iCloud MailFont AwesomejQueryPHPYoast SEOBootstrapMicrosoft IIS.

What is ITALFARMACO S.P.A.'s email format?

Minus sign iconPlus sign icon
ITALFARMACO S.P.A.'s email format typically follows the pattern of F.Last@italfarmaco.com. Find more ITALFARMACO S.P.A. email formats with LeadIQ.

When was ITALFARMACO S.P.A. founded?

Minus sign iconPlus sign icon
ITALFARMACO S.P.A. was founded in 1938.

ITALFARMACO S.P.A.

Pharmaceutical ManufacturingLombardy, Italy501-1000 Employees

Italfarmaco SpA, multinazionale italiana privata fondata nel 1938 con sede a Milano, opera in Italia e all’estero nel settore farmaceutico e chimico-farmaceutico attraverso società direttamente controllate e/o partecipate. 

Oggi il Gruppo Italfarmaco è presente con la sua attività di vendita di prodotti etici in Italia, Svizzera, Francia, Spagna, Germania, Portogallo, Grecia, Russia, Turchia, Cile, Perù, Marocco e per la consociata Chemi Spa anche USA e Brasile. 
Abbiamo moderni e sofisticati impianti industriali dove produciamo specialità medicinali in siringhe preriempite, iniettabili sterili, orali solidi e liquidi.

Il Gruppo Italfarmaco si distingue particolarmente per il suo impegno nella ricerca, principalmente orientata all'area cardiovascolare e alle malattie nell’area immunologica ed oncologica.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1938
Employees
501-1000

Section iconFunding & Financials

  • $50M$100M

    ITALFARMACO S.P.A.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    ITALFARMACO S.P.A.'s revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.